CClinicalTrials.gg
Status unknownNCT04357145AdherenceUpdated Apr 29, 2020

Exercise Dosages and Exercise Adherence With Patients With Knee Osteoarthritis

An interventional study of High Dosage Home Exercise Training and Standard Dosage Home Exercise Training in Knee Osteoarthritis, sponsored by Marmara University. Status unknown. Open to participants aged 40 Years to 85 Years. Per ClinicalTrials.gov, last updated 2020-04-29.

Sponsored by Marmara University · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Apr 2020), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
40 Years to 85 Years
Sex
All
01

Study summary

Although the effects of different exercise dosages for patients with osteoarthritis are compared in the literature, it is seen that studies on which exercise dosage is better are insufficient.The planned study has 2 main objectives:

  • To examine the effects of different exercise dosages on exercise dependence
  • To investigate the effect of different exercise dosages on pain and functional results
Read the detailed description

Knee osteoarthritis (KO) is the most common musculoskeletal problem worldwide, leading to pain and loss of locomotor function. The Framingham Osteoarthritis Study shows that 19% of adults have radiographic effects on the knee joint. Individuals with advanced symptomatic KO have difficulties in their daily life activities. Among all diseases, KO most affects activities such as walking, climbing stairs and housework. A wide range of physiotherapy treatment methods are available in KO treatment such as strengthening exercises, aquatic exercises, aerobic exercises, proprioception exercise, orthotics, taping methods and the use of electrophysiological agents. High-quality evidences suggests that land-based exercise therapy maintains its positive effect on pain, quality of life and functionality for 2-6 months after the treatment. The dosage of exercise therapy can be adjusted by the duration, frequency, or resistance of the exercise. However, evidence-based information on exercise dosage is limited in KO treatment. While KO is treated in physiotherapy clinics, it is also supported by home exercises during and after treatment. However, it is a clinical problem that patients show low adherence to home exercise. With this study, it is aimed to compare the exercise adherence of patients who are given home exercise with different exercise dosages and to show their functional results. Participants with KO aged between 40-85 years will be included in the study and randomly divided into two groups. The number of repetitions of the high dosage exercise group will be 2 times more than standard exercise group. Participants will be asked to apply home exercise programs 4 times a week. Exercise adherence, pain, kinesiophobia and functionality will be evaluated. Our study will be the first to demonstrate the effect of different home exercise dosages on exercise adherence. The information to be obtained with this study is thought to contribute to the preparation of a better home exercise program. With the information to be obtained through this study, it can contribute to the preparation of a better home exercise program.The planned study has 2 main objectives:

  • To examine the effects of different exercise dosages on exercise dependence
  • To investigate the effect of different exercise dosages on pain and functional results
02

Conditions studied

  • Knee Osteoarthritis

Keywords

  • Knee Osteoarthritis
  • Exercise Adherence
  • Exercise Dosage
  • Home Exercises
03

In context

Osteoarthritis

4,398 studies on the registry are indexed under Osteoarthritis; 583 are open to participants now.

This study's planned enrollment of 60 is below the median of 70 across 3,440 interventional studies indexed under Osteoarthritis.

Browse Osteoarthritis studies →

Lead sponsor

Marmara University is the lead sponsor of 576 studies on the registry; 136 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Having a diagnosis of unilateral or bilateral knee osteoarthritis.
  • Being between stage 1-3 according to Kellgren-Lawrence criteria.
  • Having at least 3 months of pain duration and decreased functioning.
  • Being a volunteer who can read and write

Exclusion criteria

Exclusion Criteria:

  • Physiotherapy or other conservative therapy during the previous 3 months or a history of major knee trauma.
  • Having Inflammatory joint disease, hip symptoms more aggravating than the knee symptoms,
  • Having comorbidities not allowing exercise such as cardiovascular, respiratory, systemic, or metabolic conditions limiting exercise tolerance.
  • Participants with previously performed knee replacement surgery
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Active comparator
    Standard Exercise Group

    Exercise training is given to patients in the form of a home exercise program.

    Other: Standard Dosage Home Exercise Training

  • Experimental
    High Dosage Exercise Group

    The high dosage exercise training group will implement the recommended exercise program 3 times more than the standard exercise group.

    Other: High Dosage Home Exercise Training

Interventions

  • OtherHigh Dosage Home Exercise Training

    By giving more exercise to the experimental group, exercise adherence, pain and functionality will be compared with the standard exercise group. 3 times more reputation than control Exercise Program to be Applied (0-3 Weeks): Isometric knee extensor and adductor exercise * Hamstring stretching exercise * Terminal knee extension exercise * Straight leg lifting exercise Exercise Program to be Applied (3-12 Weeks): * Stepping exercise * Sit up and stand up without support * Active knee flexion exercise * Moving forward exercise

  • OtherStandard Dosage Home Exercise Training

    5-6 standard reputations for all exercises Exercise Program to be Applied (0-3 Weeks): Isometric knee extensor and adductor exercise * Hamstring stretching exercise * Terminal knee extension exercise * Straight leg lifting exercise Exercise Program to be Applied (3-12 Weeks): * Stepping exercise * Sit up and stand up without support * Active knee flexion exercise * Moving forward exercise

06

What researchers measure

Primary outcomes

  1. Change from Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Points at 12 weeks

    (WOMAC) is a widely used, proprietary set of standardized questionnaires used by health professionals to evaluate the condition of patients with osteoarthritis of the knee and hip, including pain, stiffness, and physical functioning of the joints.The WOMAC measures five items for pain (score range 0-20), two for stiffness (score range 0-8), and 17 for functional limitation (score range 0-68). Higher scores on the WOMAC indicate worse pain, stiffness, and functional limitations.

    Time frame: Baseline, Week 3, Week 6 and Week 12

  2. Change from Exercise Adherence (with Self Reported Exercise Diary) at 12 Weeks Percentages at 12 Weeks

    In the exercise diary, the participant will note the number of exercises done at home next to the image showing the exercise example day by day.The percentage adherence to the prescribed exercise regimen was calculated by dividing the number of exercises performed by the number of exercises prescribed and multiplying by 100.

    Time frame: Week 3, Week 6, Week 9, Week 12

  3. Change from Knee Osteoarthritis Exercise Adherence Scale Points at 12 Weeks

    It consists of four yes / no questions.'Yes' answer is rated with 1 point, 'No' answer gets 0 point. Lesser scores indicate good exercise adherence.

    Time frame: Week 3, Week 6, Week 9, Week 12

Secondary outcomes

  1. Change from Visual Analogue Scale(for Pain) Points at 12 Weeks

    The pain Visual Analogue Scale(VAS) is a unidimensional measure of pain intensity, which has been widely used in diverse adult populations. VAS is a straight horizontal line of fixed length, usually 100 mm. The ends are defined as the extreme limits of the parameter to be measured pain orientated from the left (worst) to the right (best).

    Time frame: Baseline, Week 3, Week 6 and Week 12

  2. Change from Tampa Scale for Kinesiophobia Points at 12 Weeks

    The term kinesiophobia refers to a fear of pain with movement - i.e., movements which a patient is hesitant to perform due to fear that the movement will elicit pain. Likert scoring with 4 points (1 = Strongly disagree, 4 = I totally agree) is used in the scale. Tampa Scale for Kinesiophobia consists of 17 questions. A score of 17 is the lowest possible score, and indicates no kinesiophobia or negligible. A score of 68 is the highest possible score and indicates extreme fear of pain with movement. A total score is calculated after inversion of the individual scores of items 4, 8, 12 and 16.

    Time frame: Baseline, Week 3, Week 6 and Week 12

  3. Change from Timed Up&Go Test Score at 12 Weeks

    The timed up and walk test(TUG) is used to measure the time it takes for the patient to get up from the chair, walk a distance of 3m, turn and sit on the same chair. TUG is a simple test used to assess a person's mobility and requires both static and dynamic balance. One source suggests that scores of ten seconds or less indicate normal mobility, 11-20 seconds are within normal limits for frail elderly and disabled patients, and greater than 20 seconds means the person needs assistance outside and indicates further examination and intervention.

    Time frame: Baseline, Week 3, Week 6 and Week 12

  4. Change from Timed 10 Meter Walk Test Score at 12 Weeks

    The 10 Metre Walk Test is a performance measure used to assess walking speed in metres per second over a short distance. It can be employed to determine functional mobility, gait, and vestibular function. The participant walks without assistance for 10 metres, with the time measured for the intermediate 6 metres to allow for acceleration and deceleration.

    Time frame: Baseline, Week 3, Week 6 and Week 12

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 29, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04357145
Lead sponsor
Marmara University
Responsible party
Eda Tonga (Doctor of Philosophy, Marmara University) — Principal investigator
First posted
Apr 22, 2020
Start date
Jun 1, 2020 (estimated)
Primary completion
Sep 30, 2020 (estimated)
Completion
Oct 30, 2020 (estimated)
Last update
Apr 29, 2020

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion